Christophe Thurieau
Algemeen Directeur bij Symphogen A/S
Profiel
Christophe Thurieau is the Chief Executive Officer & Director at Symphogen A since 2020.
Prior to this, he worked as Senior Vice President-Scientific Affairs at Ipsen SA and as a Member-Management Board at PregLem SA. He completed his undergraduate degree from Harvard University and received his doctorate from Université Pierre et Marie Curie in 1988.
Actieve functies van Christophe Thurieau
| Bedrijven | Functie | Begin |
|---|---|---|
Symphogen A/S
 Symphogen A/S Pharmaceuticals: MajorHealth Technology Symphogen A/S provides antibody therapeutics for the treatment of cancers. It offers oncology products and creates selected antibody mixtures that address multiple oncology targets in a single drug product. The firm’s pipeline is fueled by its technology suite capable of identifying, selecting, manufacturing, and characterizing optimal antibody mixtures. The company was founded by Kirsten Aarup Drejer, Thomas Feldthus, Eigil Bjerl Nielsen, Anker Gunvald Lundemose, Kim Arthur Hueg, and John Soerensen Haurum in 2000 and is headquartered in Ballerup, Denmark. | Algemeen Directeur | 04-06-2020 |
Eerdere bekende functies van Christophe Thurieau
| Bedrijven | Functie | Einde |
|---|---|---|
| IPSEN | Corporate Officer/Principal | - |
PregLem SA
 PregLem SA Pharmaceuticals: MajorHealth Technology PregLem SA manufactures and markets pharmaceutical products specializing in gynecology and women's reproductive health. Its products include ESMYA, PGL2001, and PGL1001. The company was founded in June 2006 and is headquartered in Geneva, Switzerland. | Directeur/Bestuurslid | - |
Opleiding van Christophe Thurieau
| Harvard University | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| IPSEN | Health Technology |
| Bedrijven in privébezit | 3 |
|---|---|
PregLem SA
PregLem SA Pharmaceuticals: MajorHealth Technology PregLem SA manufactures and markets pharmaceutical products specializing in gynecology and women's reproductive health. Its products include ESMYA, PGL2001, and PGL1001. The company was founded in June 2006 and is headquartered in Geneva, Switzerland. | Health Technology |
| Université Pierre et Marie Curie | Consumer Services |
Symphogen A/S
Symphogen A/S Pharmaceuticals: MajorHealth Technology Symphogen A/S provides antibody therapeutics for the treatment of cancers. It offers oncology products and creates selected antibody mixtures that address multiple oncology targets in a single drug product. The firm’s pipeline is fueled by its technology suite capable of identifying, selecting, manufacturing, and characterizing optimal antibody mixtures. The company was founded by Kirsten Aarup Drejer, Thomas Feldthus, Eigil Bjerl Nielsen, Anker Gunvald Lundemose, Kim Arthur Hueg, and John Soerensen Haurum in 2000 and is headquartered in Ballerup, Denmark. | Health Technology |
